Imaging Technology

MAY 30, 2023

It represents a new class of purposely engineered, high-affinity PSMA-targeted radiopharmaceuticals based on novel radiohybrid technology, which may offer diagnostic imaging and therapeutic potential. Blue Earth Diagnostics received U.S. The adverse reactions reported in ≥0.4%

Diagnostic 97

Diagnostic Imaging Radiopharmaceuticals Diagnostic Imaging 97

Associates in Medical Imaging

FEBRUARY 15, 2021

Hospitals and medical practices of all sizes, no matter their target demographic or geographical location, often struggle to ensure their patients have access to all of the essential imaging modalities necessary to diagnose a wide variety of medical conditions.

Magnetic Resonance Imaging 52

Magnetic Resonance Imaging Imaging Modalities Diagnostic MRI 52

AuntMinnie

MARCH 26, 2024

This theranostic therapy first demonstrated how using diagnostic imaging with a radioactive probe, gallium-68 (Ga-68 dotatate injection), could locate NETs on PET scans. This drug relies on a gallium Ga-68, too, as a diagnostic imaging agent.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

AuntMinnie

JUNE 20, 2024

This theranostic therapy first demonstrated how using diagnostic imaging with a radioactive probe, gallium-68 (Ga-68 dotatate injection), could locate NETs on PET scans. This drug relies on a gallium Ga-68, too, as a diagnostic imaging agent.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52

Independent Imaging

APRIL 24, 2020

Diagnostic imaging plays a very important role in modern medicine. It allows physicians to diagnose and treat many different health conditions, injuries, and diseases more accurately and easily. A CT (computerized tomography) scan is used to enable doctors to see clear images of the structures and tissues of your body.

X-ray 52

X-ray Diagnostic Imaging Radiologist Imaging 52

Imaging Technology

MAY 2, 2023

For example, results showed that among the subgroup (n=76) of patients in the Evaluable PET Scan Population who had undergone primary treatment with radiation therapy for prostate cancer, the overall patient-level DR was 99% (75/76) and consistently high across the three independent readers (range 93-99%).

Diagnostic 98

Diagnostic Radiopharmaceuticals Imaging Radiation 98